06872.HK
TENNOR THERAP-B
HKSE · Healthcare · Biotechnology · CN
HKD 70.20
−6.40%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- -6.2%
- EBIT
- -52.1%
- Net income
- -5.0%
- EPS
- -5.0%
- Free cash flow
- -79.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025